“The Assessment Of The Complementary Chemotherapeutic Potential Of Nigella Sativa In Patients With Colorectal Cancer: A Randomized Clinical Trial” (2023) Journal of Pharmaceutical Negative Results, pp. 635–643. doi:10.47750/pnr.2023.14.04.76.